Voriconazole-associated Severe Hyponatremia
Overview
Veterinary Medicine
Authors
Affiliations
Voriconazole is the drug of choice for invasive aspergillosis. We describe three patients who presented with severe hyponatremia after the initiation of voriconazole treatment. One patient expired while the other two patients recovered after a dose adjustment or discontinuation of the antifungal. The voriconazole trough levels were checked in all and two were elevated. These findings mandate monitoring electrolyte levels during voriconazole therapy.
Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents.
Benitez L, Carver P Drugs. 2019; 79(8):833-853.
PMID: 31093949 DOI: 10.1007/s40265-019-01127-8.
Farkas A, Daroczi G, Villasurda P, Dolton M, Nakagaki M, Roberts J Antimicrob Agents Chemother. 2016; 60(11):6806-6812.
PMID: 27600031 PMC: 5075089. DOI: 10.1128/AAC.00970-16.
Ahmadzai H, Raley D, Masters L, Davies M J Surg Case Rep. 2014; 2013(4).
PMID: 24964429 PMC: 3635217. DOI: 10.1093/jscr/rjt018.
Therapeutic drug monitoring in voriconazole-associated hyponatremia.
Xu R, Zheng S, Xiao L, Cai X, Lai X, Lin G Med Mycol Case Rep. 2014; 2:134-6.
PMID: 24432238 PMC: 3885944. DOI: 10.1016/j.mmcr.2013.06.003.
Ashbee H, Barnes R, Johnson E, Richardson M, Gorton R, Hope W J Antimicrob Chemother. 2014; 69(5):1162-76.
PMID: 24379304 PMC: 3977608. DOI: 10.1093/jac/dkt508.